Gracell Biotechnologies Inc.: share_based_compensation
| Value | {"unit": "CNY", "value": 26874000, "concept": "us-gaap:ShareBasedCompensation"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/78fe8589-3bcc-434e-a3d6-d797fa984587
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-221202Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/share-based-compensation/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/78fe8589-3bcc-434e-a3d6-d797fa984587
History
- no predecessors — first report